ArticleThe international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease2023
Clinical standards for diagnosis, treatment and prevention of post-COVID-19 lung disease.
Open access · hybridAbstract read
In one paragraph
Article in The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.
0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
2.5field-weighted citation impact, top 10% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
9 citing papers in PubMed, 12 citations in OpenAlex.
- Respiratory symptoms up to 18 months after COVID-19 - a longitudinal observational study.Respiratory research · 2026Observational
- Assessment and management of post-COVID-19 pulmonary complications: a rapid review.European respiratory review : an official journal of the European Respiratory Society · 2026Review
- Article
- Effect of water- and land-based exercise on lung function in children with post-COVID-19 condition: secondary results from a randomised controlled trial.ERJ open research · 2025Article
- Viewpoint on WHO implementation guidance on tuberculosis infection prevention and control.The European respiratory journal · 2024Article
- TB survivors: why curing TB is sometimes not enough.IJTLD open · 2024Article
- 2022 TB programme review in Pakistan: strengthening governance, with better patient diagnosis and treatment.IJTLD open · 2024Article
- Standards for clinical trials for treating TB.The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease · 2023Article
- Long-term outcomes of the global tuberculosis and COVID-19 co-infection cohort.The European respiratory journal · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
40 authors at 20 institutions in 16 countries.
D ViscaDivision of Pulmonary Rehabilitation, Istituti Clinici Scientifici (ICS) Maugeri, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Tradate, Department of Medicine and Surgery, Respiratory Diseases, University of Insubria, Varese.
R CentisRespiratory Diseases Clinical Epidemiology Unit, Istituti Clinici Scientifici Maugeri, IRCCS, Tradate.
E PontaliDepartment of Infectious Diseases, Galliera Hospital, Genoa, Italy.
E ZampognaDivision of Pulmonary Rehabilitation, Istituti Clinici Scientifici (ICS) Maugeri, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Tradate.
A-M RussellFaculty of Health and Life Sciences, University of Exeter, Exeter, Royal Devon University Hospitals NHS Trust, Exeter, North Bristol NHS Trust, Bristol, UK.
G B MiglioriRespiratory Diseases Clinical Epidemiology Unit, Istituti Clinici Scientifici Maugeri, IRCCS, Tradate.
C AndrejakRespiratory Department, Centre Hospitalier Universitaire Amiens Picardie, Amiens, Unité de Recherche 4294, Agents Infectieux, Résistance et Chimiothérapie, Picardie Jules Verne University, Amiens, GREPI (Group pour la Recherche et enseignement en pneumo-infectiologie) Work group of French society of respiratory diseases, Paris, France.
M AroFinnish Lung Health Association (FILHA), Helsinki, Finland.
H BayramDepartment of Pulmonary Medicine, Koc University Research Center for Translational Medicine, Koc University School of Medicine, Istanbul, Turkey.
K BerkaniPierre de Soleil Clinic, Respiratory Rehabilitation, Vetraz Monthoux, France.
J BruchfeldDepartment of Infectious Diseases, Karolinska University Hospital, Stockholm, Division of Infectious Diseases, Department of Medicine, Karolinska Institutet, Stockholm, Sweden.
J M ChakayaDepartment of Medicine, Therapeutics and Dermatology, Kenyatta University, Nairobi, Kenya, Department of Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, UK.
J Chorostowska-WynimkoDepartment of Genetics and Clinical Immunology, National Institute of Tuberculosis and Lung Diseases, Warsaw, Poland.
B CrestaniUniversité Paris Cité, Physiopathologie et épidémiologie des maladies respiratoires, Institut national de la santé et de la recherche médicale (INSERM), Paris, Assistance Publique des Hôpitaux de Paris (APHP), Hôpital Bichat, Service de Pneumologie A, FHU APOLLO, Paris, France.
M P DalcolmoHélio Fraga Reference Center, Fundação Oswaldo Cruz (Fiocruz), Rio de Janeiro, RJ, Brazil.
L D'AmbrosioPublic Health Consulting Group, Lugano, Switzerland.
A-T Dinh-XuanService de Physiologie-Explorations Fonctionnelles, APHP, Hôpital Cochin, Université Paris Cité, Paris, France.
S Duong-QuyRespiratory Department, Lam Dong Medical College, Dalat, Vietnam.
C FernandesHeart Institute, Cardio-pulmonology Department, University of Sao Paulo, Sao Paulo, SP, Brazil.
J-M García-GarcíaTuberculosis Research Programme (PII-TB), Sociedad Española de Neumología y Cirugía Torácica, Barcelona, Spain.
A de Melo KawassakiServiço de Pneumologia, Instituto do Câncer do Estado de São Paulo (ICESP) e do ambulatÓrio de Doenças Pulmonares Intersticiais, Hospital das Clínicas, Universidade de São Paulo, São Paulo, SP, Brazil.
L CarrozziDepartment of Surgical, Medical, and Molecular Pathology and Critical Care Medicine, University of Pisa, Pisa, Pulmonary Unit, Cardiothoracic and Vascular Department, University Hospital of Pisa, Pisa, Italy.
M A Martinez-GarciaRespiratory Department, University and Polytechnic La Fe Hospital, Valencia, Centro de InvestigaciÓn Biomédica en Red, Respiratory Disorders, Madrid, Spain.
P Carreiro MartinsAllergy and Clinical Immunology Department, Dona Estefânia Hospital, Centro Hospitalar Universitário de Lisboa Central, Lisbon, NOVA Medical School-Comprehensive Health Research Center, Lisbon, Portugal.
M MirsaeidiDivision of Pulmonary and Critical Care, University of Florida, Jacksonville, FL, USA.
Y MohammadAl Sham private University, Faculty of Medicine and Pharmacy, Damascus and Latakia, Centre for Research on Chronic Respiratory Diseases, Tishreen University, Lattakia, Syria.
R N NaidooDiscipline of Occupational and Environmental Health, University of KwaZulu-Natal, Durban, South Africa.
N NeuparthAllergy and Clinical Immunology Department, Dona Estefânia Hospital, Centro Hospitalar Universitário de Lisboa Central, Lisbon, NOVA Medical School-Comprehensive Health Research Center, Lisbon, Portugal.
L SeseDepartment of Physiology and Functional Explorations, Hôpital Avicenne, INSERM, Unité mixte de recherche 1272 Hypoxia and the Lung, Université Sorbonne Paris Nord, Bobigny, Department of Pneumology, Centre Constitutif de référence des maladies pulmonaires rares, Hôpital Avicenne, Bobigny, France.
D R SilvaFaculdade de Medicina, Universidade Federal do Rio Grande do Sul, Porto Alegre, RS, Brasil.
I SolovicNational Institute for TB, Lund Diseases and Thoracic Surgery, Vysne Hagy, Catholic University, Ruzomberok, Slovakia.
T M SooronbaevDepartment of Respiratory Medicine, National Center for Cardiology and Internal Medicine, Bishkek, Kyrgyzstan.
A SpanevelloDivision of Pulmonary Rehabilitation, Istituti Clinici Scientifici (ICS) Maugeri, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Tradate, Department of Medicine and Surgery, Respiratory Diseases, University of Insubria, Varese.
N SverzellatiDepartment of Medicine and Surgery, University of Parma, Parma, Italy.
L TannoInstitut Desbrest of Epidemiology and Santé Publique, INSERM & Montpellier University, Montpellier and Department of Allergic and Respiratory Diseases, Montpellier University Hospital, Montpellier, France.
S TiberiBlizard Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK.
T VasankariFILHA, Helsinki, University of Turku, Department of Pulmonary Diseases and Clinical Allergology, Turku, Finland.
E VasarmidiDepartment of Respiratory Medicine and Laboratory of Molecular and Cellular Pneumonology, School of Medicine, University of Crete, Heraklion, Greece.
M VitaccaICS Maugeri IRCCS, Respiratory Rehabilitation of the Institute of Lumezzane, Brescia, Italy.
I Annesi-MaesanoInstitut Desbrest of Epidemiology and Santé Publique, INSERM & Montpellier University, Montpellier and Department of Allergic and Respiratory Diseases, Montpellier University Hospital, Montpellier, France.
Istituti Clinici Scientifici Maugeri · ITCentre Hospitalier Universitaire de Montpellier · FRAzienda Ospedaliera Universitaria Pisana · ITCatholic University in Ruzomberok · SKCentre Hospitalier Universitaire Amiens-Picardie · FRCentro de Investigación Biomédica en Red · ESEnte Ospedaliero Ospedali Galliera · ITFinnish Lung Health Association · FIFundação Oswaldo Cruz · BRHôpital Avicenne · FRHospital de Dona Estefânia · PTInserm · FRInstituto do Câncer do Estado de São Paulo · BRKarolinska University Hospital · SEKoç University · TRLiverpool School of Tropical Medicine · GBNational Center of Cardiology and Internal Medicine · KGPulmonary and Critical Care Associates · USQueen Mary University of London · GBSociedad Española de Neumología y Cirugía Torácica · ES
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
COVID-19Quality of LifeCOVID-19 TestingDisease ProgressionEducational StatusExerciseHumans
Identifiers
What Socratic holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.